Mechanistic Modeling of the Human Central Nervous System Pharmacokinetics to Inform Brain Cancer Drug Development & Treatment

Time: 3:45 pm
day: Conference Day One


  • Applying PBPK modeling for mechanistic and quantitative prediction of system and CNS PK in patients
  • Discussing how the PBPK modeling of CNS pharmacokinetics can be used to assist the selection of the right drug, dosing schedule, and route of administration for rational trial design and optimal treatment of brain cancer